Infographic: Racing to Vaccinate Against COVID-19
The COVID-19 pandemic has cost lives and caused much fear in Canada. With Canadians now eagerly waiting for vaccines, Nigel ...
Tag: Nigel Rawson
COVID-19 research in Canada reveals Ottawa’s unwillingness to collaborate: Nigel Rawson and John Adams for Inside Policy
Canadian governments, at all levels, must take responsibility for their inept procurement and distribution processes in their health systems, write ...
Use COVID pause to reconsider drug-price regulation: Nigel Rawson and John Adams in the Financial Post
Canadians need Ottawa to work with the pharmaceutical industry, clinicians and patients to improve access to new medicines and vaccines, ...
Our vaccine gap reflects years of policy self-harm: Nigel Rawson, Olaf Koester, and John Adams in the Financial Post
The prime minister has committing to ensuring developing nations get access to the long awaited vaccine, but what is his ...
The Patented Medicine Prices Review Board is selling Canadians a lemon: Nigel Rawson for Inside Policy
The federal government is pursuing an aggressive agenda using untried methods to regulate extremely low drug prices, writes Nigel Rawson. ...
COVID-19 Highlights Weaknesses in Canada’s System for New Medicines: MLI report by Rawson and Adams
OTTAWA, ON (June 18, 2020): The COVID-19 pandemic has revealed numerous weaknesses in Canadian health care, and as the world ...
Don’t let price controls delay access to a vaccine: Nigel Rawson and Olaf Koester in the Financial Post
Unless Ottawa guarantees the price or postpones the PMPRB revisions, manufacturers will not know whether a tendered price is compliant ...
MLI experts available to comment on delay to federal drug price reduction scheme
OTTAWA, ON (June 2, 2020): Changes to the Patented Medicine Prices Review Board (PMPRB) have been delayed until January 2021 ...
Government refuses to address real cause of missing cystic fibrosis treatment in Canada: Nigel Rawson in National Newswatch
Nothing fair exists in denying Canadian cystic fibrosis patients approved and funded access to treatments that they have been waiting ...
COVID-19, other rare disorders and the rescue principle: Nigel Rawson and John Adams for Inside Policy
Lower ceiling prices for new medicines will make Canada less attractive as a country for new drugs and vaccines, making ...
Pan-Canadian Pharmaceutical Alliance Lacks Transparency and Accountability: Nigel Rawson for Inside Policy
Negotiations to limit drug prices should not limit patients’ access to innovative drugs, writes Nigel Rawson. By Nigel Rawson, February ...
-
Holding the government accountable for using the Emergencies Act: Ryan Alford for Inside Policy
-
The frontline voices: Tigrayans speak on the realities of life under an insurgency regime
-
Sovereignty in the Arctic and the struggles of the CC-295 Kingfisher: Richard Shimooka in the Hill Times
-
How should NATO respond to Russia’s challenge to European security and stability? New MLI report
-
Canadian Surface Combatant program remains best option for Royal Canadian Navy: Richard Shimooka in the Hill Times
